Seeking Alpha

candooman

candooman
Send Message
View as an RSS Feed
View candooman's Comments BY TICKER:
Latest  |  Highest rated
  • New commercial chief at Advanced Cell Tech [View news story]
    Here is a quote from ACTC's press release:


    "Platelets play a critical role in stimulating clot formation, repair of vascular injury and wound healing. The current supply of platelets is limited due to their short five (5) day storage time."
    Oct 20, 2014. 03:05 PM | 1 Like Like |Link to Comment
  • New commercial chief at Advanced Cell Tech [View news story]
    The CEO is thinking big, really big. The impact of getting off a Universal Platelet on ACTC will be hugh. I do not know how long it will take to get FDA approval but since it is only a platelet, meaning, it is for supporting life, not rebulding cells or fighting disease, it could be much shorter approval process. ACTC will need a big pharma partner who has a well established distribution and commercial network --- worldwide. Universal palatelet will replace normal blood platelets which require blood donors who are different types, can carry diseases like HIV, Hepatitis A/C, etc. Unlike normal blood platelet which spoils after 5 days, this one has no limits, great for battlefield hospital use..... including in disasters. This is where this Commercialization guy comes in. He has a big job ahead of him.

    http://yhoo.it/1wrcBgd

    I am waiting for Seeking Alpha contributors to issue a writeup on this.
    Oct 20, 2014. 12:43 PM | 3 Likes Like |Link to Comment
  • Advanced Cell Technology Has Groundbreaking Results [View article]
    Universal Platelet. This is going to be a hugh business once approved by the FDA..... will dwarf SMD and AMD business. Unlike SMD and AMD which are one time treatment for individuals, platelets are always needed in clinics, hospitals, b y military medics, etc., to treat people who need blood transfusion.

    http://yhoo.it/1wrcBgd

    The need for a universal platelets is world wide. This is the kind of business that ACTC will need a big established pharma partner.

    Any opinion on this?
    Oct 20, 2014. 10:41 AM | 1 Like Like |Link to Comment
  • Advanced Cell Technology Has Groundbreaking Results [View article]
    News today on iPS cells based blood plasma created by ACTC will bring in income that is several fold bigger than SMD and AMD. Hundreds of Millions of sick people around the world need a universal germ/bacteria/virus free blood plasma that has a very long shelf life to survive treatments. This is the one product that could propel ACTC shares to reach over $100.
    Oct 17, 2014. 10:29 PM | 2 Likes Like |Link to Comment
  • Advanced Cell Technology Has Groundbreaking Results [View article]
    If I heard it right, AMD is 50 patients not 30.

    I think the reason for getting more SMD patients is because they are younger (some are only in their teens when they get it) and hence, cells will take better engraftment. Keep in mind ACTC asked the FDA for approval of Ph 1b which targets younger patients. Their experience with the older patients perhaps showed that they could possibly get much better results with younger patients. I was expecting them to say something about this during the CC but they did not. The SMD patient interviewed on NPR said he had great results.
    Oct 16, 2014. 01:44 PM | 1 Like Like |Link to Comment
  • RPE cells safety data published online in The Lancet [View news story]
    WOW! Thanks for sharing. Looks like the patients are getting close to normal vision. This is remarkable. One question though. Only one eye get the treatment. Now that the vision improvement on one eye is remarkable, what are the researchers/ACTC plans with the other eye? I know they need to leave the untreated eye as reference, but we also know they continue to deteriorate. How much longer are they going to wait until they treat it?
    Oct 15, 2014. 10:44 PM | Likes Like |Link to Comment
  • Advanced Cell Technology Has Groundbreaking Results [View article]
    You can find more information here than from the CC this afternoon.

    http://bit.ly/11nVdNL?cmpid=RSS|NSNS|2012-G...
    Oct 15, 2014. 09:15 PM | 1 Like Like |Link to Comment
  • Advanced Cell Technology Has Groundbreaking Results [View article]
    The conference call was the same as the press release, with a little bit more information, delivered without passion in their voices. Very disappointing. The trial showed good results, confirming what many have speculated. But the presentation was so dry. Unless you have been following the trials progress these past 3 years, it does not sound like there is a bright future for the company. They seem to be so afraid of making forward looking statements. I am afraid the pps will be going south.

    However, when looked at in a rational way, the business should be good. As a minimum, the treatment arrests the progress of AMD and SMD. Because there is no treatment available, on stopping the disease progress alone, the process can be approved by the FDA, especially since 2/3 rds of the patients showed improvement in their vision. In Phase 2, with all patients to be treated with the higher dosage (150,000 cells or more depending on the results of the 200K dosage) it is likely the results will be the restoration of vision good enough "to ride on a horse" and see where one is going. [This is what was missing on the CC, details on who got better vision, the dosage and over what period of time. They just said it was safe and implied that the FDA gave them approval to proceed to Ph 2. Did they expect us to get a copy of the Lancet and read the article ourselves?]

    I hope someone who has access to the Lancet will read it and provide us with a trial result summary. I have high hopes on cell cures so I am holding on to my shares. In baseball parlance, ACTC Management opted to bunt today and made no attempt to make a hit.
    Oct 15, 2014. 07:40 PM | 1 Like Like |Link to Comment
  • Advanced Cell Technology Has Groundbreaking Results [View article]
    This is a disappointment. Second announcement and no Q & A. .... and little specifics on the trial results, just broad statements. They mentioned that they will be making presentations.... I hope there will be Q&A at that time.

    The Ph 2 timelines for SMD and AMD seem to be stretched relative to what they already know from Ph 1/2. I am afraid competitors are going to catch up and pass them.
    Oct 15, 2014. 04:55 PM | Likes Like |Link to Comment
  • Update: Advanced Cell Technology Interim Results And Shelf Offerings [View article]
    This is a big BS article from Esekla. Stopping deterioration of the eyes is a big deal. The untreated eye continued to deteriorate. But it is more than that. The patients can see to 4 levels in the eye chart .... from none. As Dr Lanza said, they can see enough to go horse riding. Here is the other article you should read:

    http://bit.ly/11nVdNL?cmpid=RSS|NSNS|2012-G...

    I am expecting ACTC's Dr Lanza will discuss trial results in detail this afternoon at the 1PM PST conference call. I hope he talks about the result of Phase 1b which is treatment of younger people at 150,000 cell dosage. That is the group that should get better results, perhaps bring it up to 20/40 at the very least.
    Oct 15, 2014. 12:09 PM | 6 Likes Like |Link to Comment
  • Forget Keystone - Canada moves toward oil route around Obama [View news story]
    This might actually be a better deal the the Keystone pipeline. Why? Next step for the US and EU to stop Russian aggression towards its neighbors is not to buy its oil. This will reduce the money available for Russia to wage war. This pipeline will make it easier for the EU to decide if an easy alternative source is available. For this to work Canada needs to get construction started sooner than 2016. Obama and the Democrats have proven to be unreliable partners. This will take them out of the equation.
    Oct 8, 2014. 08:25 PM | 6 Likes Like |Link to Comment
  • Advanced Cell Technology And Dilution: Do We Really Have A Rational Choice? [View article]
    Competition uses different methods to achieve the same goal. I believe, what research on stem/adult cells have shown, that stem cells have the advantage of lasting as long as a normal human life. Adult cells like iPSCs have limited life span and therefore, may not be suited to get long term multi year benefits. ACTC is the only one using HeSC.
    Oct 1, 2014. 03:23 PM | Likes Like |Link to Comment
  • Axion Power: Out Of The PIPE And Into The Light - Part II [View article]
    That is good news. I hope those people listening to you came out with a good understanding of the PbC batteries. I also hope ePower gets some orders as a result of demonstrating their cab tractor at their exhibit. Nothing like putting ones eyes and hands on the real thing.

    The stock price has been slowly declining since the R/S and only news of significant new orders for Axion products can reverse the slide. It better come soon or it gets delisted.
    Sep 23, 2014. 01:55 PM | 2 Likes Like |Link to Comment
  • A Repudiation Of Advanced Cell Technology's 'Whisper' Results [View article]
    Please note that one thing the teams does after cell injection is "look inside the eye" and see if the cells have implanted and if it is holding. If the eye has cataract or film, they cannot see inside the eye and therefore, will not know the result. The patient that is on trial should have no eye problem whatsoever that will impede full examination of the eyes. Hence the criteria on cataract time requirements.
    Sep 22, 2014. 05:09 PM | Likes Like |Link to Comment
  • Axion Power: Out Of The PIPE And Into The Light - Part II [View article]
    Hi John,

    How was the showgoer's reception to the AXPW booth go during the Battery Show last week? I hope your 15 minute speech came out well.
    Sep 22, 2014. 02:16 PM | Likes Like |Link to Comment
COMMENTS STATS
326 Comments
502 Likes